Huber K - Search Results

1

Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation.

Hohensinner PJ, Lenz M, Haider P, Mayer J, Richter M, Kaun C, Goederle L, Brekalo M, Salzmann M, Sharma S, Fischer MB, Stojkovic S, Ramsmayer D, Hengstenberg C, Podesser BK, Huber K, Binder CJ, Wojta J, Speidl WS. Hohensinner PJ, et al. Among authors: huber k. Biochem Pharmacol. 2021 Aug;190:114634. doi: 10.1016/j.bcp.2021.114634. Epub 2021 May 28. Biochem Pharmacol. 2021. PMID: 34058186 Free article.

2

HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.

Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J. Wiesbauer F, et al. Among authors: huber k. Br J Pharmacol. 2002 Jan;135(1):284-92. doi: 10.1038/sj.bjp.0704454. Br J Pharmacol. 2002. PMID: 11786505 Free PMC article.

3

C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.

Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, Fritsch G, Printz D, Binder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P. Wojta J, et al. Among authors: huber k. Blood. 2002 Jul 15;100(2):517-23. doi: 10.1182/blood.v100.2.517. Blood. 2002. PMID: 12091343 Free article.

4

High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease.

Speidl WS, Graf S, Hornykewycz S, Nikfardjam M, Niessner A, Zorn G, Wojta J, Huber K. Speidl WS, et al. Among authors: huber k. Am Heart J. 2002 Sep;144(3):449-55. doi: 10.1067/mhj.2002.124353. Am Heart J. 2002. PMID: 12228781

5

Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.

Mehrabi MR, Serbecic N, Tamaddon F, Kaun C, Huber K, Pacher R, Wild T, Mall G, Wojta J, Glogar HD. Mehrabi MR, et al. Among authors: huber k. Cardiovasc Res. 2002 Nov;56(2):214-24. doi: 10.1016/s0008-6363(02)00591-6. Cardiovasc Res. 2002. PMID: 12393092

6

Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.

Prager M, Türel Z, Speidl WS, Zorn G, Kaun C, Niessner A, Heinze G, Huk I, Maurer G, Huber K, Wojta J. Prager M, et al. Among authors: huber k. Stroke. 2002 Dec;33(12):2756-61. doi: 10.1161/01.str.0000039322.66575.77. Stroke. 2002. PMID: 12468766 Clinical Trial.

7

Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.

Macfelda K, Weiss TW, Kaun C, Breuss JM, Zorn G, Oberndorfer U, Voegele-Kadletz M, Huber-Beckmann R, Ullrich R, Binder BR, Losert UM, Maurer G, Pacher R, Huber K, Wojta J. Macfelda K, et al. Among authors: huber beckmann r, huber k. J Mol Cell Cardiol. 2002 Dec;34(12):1681-91. doi: 10.1006/jmcc.2002.2117. J Mol Cell Cardiol. 2002. PMID: 12505065

8

2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves.

Pfaffenberger S, Devcic-Kuhar B, El-Rabadi K, Gröschl M, Speidl WS, Weiss TW, Huber K, Benes E, Maurer G, Wojta J, Gottsauner-Wolf M. Pfaffenberger S, et al. Among authors: huber k. Thromb Haemost. 2003 Mar;89(3):583-9. Thromb Haemost. 2003. PMID: 12624644

9

Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway.

Niessner A, Kaun C, Zorn G, Speidl W, Türel Z, Christiansen G, Pedersen AS, Birkelund S, Simon S, Georgopoulos A, Graninger W, de Martin R, Lipp J, Binder BR, Maurer G, Huber K, Wojta J. Niessner A, et al. Among authors: huber k. J Infect Dis. 2003 Jul 1;188(1):108-13. doi: 10.1086/375827. Epub 2003 Jun 12. J Infect Dis. 2003. PMID: 12825178

10

Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.

Steiner S, Seidinger D, Huber K, Kaun C, Minar E, Kopp CW. Steiner S, et al. Among authors: huber k. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1697-702. doi: 10.1161/01.ATV.0000087035.46547.89. Epub 2003 Jul 17. Arterioscler Thromb Vasc Biol. 2003. PMID: 12869353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,101 results

Search Page

Filters